Development of the Treatment Adherence Survey-patient version (TAS-P) for OCD

Journal of Anxiety Disorders

Volumn 22, Issue 1, 2008, Pages 32-43

  Mancebo, Maria C ^a,b   Pinto, Anthony ^a,b   Rasmussen, Steven A ^a,b   Eisen, Jane L ^a  

^a BROWN UNIVERSITY   (United States)

^b BUTLER HOSPITAL   (United States)

Author keywords

Cognitive Behavioral Therapy; Obsessive Compulsive Disorder; Pharmacotherapy; Psychometric properties; Treatment adherence

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL ARTICLE; COGNITIVE THERAPY; CONCURRENT VALIDITY; FEMALE; HUMAN; MALE; MENTAL DISEASE; OBSESSIVE COMPULSIVE DISORDER; PATIENT COMPLIANCE; PROSPECTIVE STUDY; PSYCHOMETRY; PSYCHOPHARMACOTHERAPY; SELF REPORT; STRUCTURED INTERVIEW; TREATMENT ADHERENCE SURVEY PATIENT VERSION; TREATMENT OUTCOME;

ADULT; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; PATIENT COMPLIANCE; PSYCHOLOGICAL TESTS; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS;

EID: 37249084668     PISSN: 08876185     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.janxdis.2007.01.009     Document Type: Article

References (23)

1. Blumenthal R., and Endicott J. Barriers to seeking treatment for major depression. Depression and Anxiety 4 6 (1996) 273-278
2. Clark L.A., and Watson D. Constructing validity: basic issues in objective scale development. Psychological Assessment 7 3 (1995) 309-319
3. Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 20 (1960) 37-46
4. Denys D., Van Megen H.J., and Westenberg H.G. The adequacy of pharmacotherapy in outpatients with obsessive-compulsive disorder. International Clinical Psychopharmacology 17 (2002) 109-114
5. DiMatteo M.R., Hayes R.D., Gritz E.R., Bastani R., Crane L., Elashoff R., et al. Patient adherence to cancer control regimens: scale development and initial validation. Psychological Assessment 5 1 (1993) 102-112
6. Eisen J.L., Goodman W.K., Keller M.B., Warshaw M., DeMarco L.M., Luce D.D., et al. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. Journal of Clinical Psychiatry 60 5 (1999) 346-351
7. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV Axis I Disorders-Patient Edition, version 2.0 (1996), Biometrics Research Department, New York State Psychiatric Institute, New York
8. Foa E.B., Grayson J.B., Steketee G., Doppelt H.G., Turner R.M., and Latimer P. Success and failure in the behavioral treatment of obsessive-compulsives. Journal of Consulting and Clinical Psychology 51 (1983) 287-297
9. Foa E.B., Liebowitz M.R., Kozak M.J., Davies S., Campeas R., Franklin M.E., et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. American Journal of Psychiatry 162 1 (2005) 151-161
10. Franklin M.E. Combining serotonin medication with cognitive-behavior therapy: is it necessary for all OCD patients?. In: Abramowitz J.S., and Houts A.C. (Eds). Concepts and controversies in Obsessive-Compulsive Disorder (2005), Springer, New York 377-390
11. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischman R.L., Hill C.L., et al. The Yale-Brown obsessive-compulsive scale: I. Development, use and reliability. Archives of General Psychiatry 46 (1989) 1006-1011
12. Greist J., Jefferson J., Kobak K., Katzelnick D., and Serlin R. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: A meta-analysis. Archives of General Psychiatry 52 1 (1995) 53-60
13. Greist J.H., and Baer L. Psychotherapy for obsessive-compulsive disorder. In: Stein D., and Hollander E. (Eds). Textbook of Anxiety Disorders (2002), Washington, DC, American Psychiatric Publishing
14. Hamilton M. A rating scale for depression. Journal of Neurology and Neurosurgical Psychiatry 23 (1960) 56-62
15. Jenike M.A. Drug treatment of obsessive-compulsive disorders. In: Jenike M., Baer L., and Minichiello W.E. (Eds). Obsessive compulsive disorders: practical management. 3rd ed. (1998), Mosby Inc., New York 469-532
16. Kozak M.J., and Coles M.E. Treatment for OCD: unleashing the power of exposure. In: Abramowitz J.S., and Houts A.C. (Eds). Concepts and controversies in Obsessive-Compulsive Disorder (2005), Springer, New York 283-304
17. Mancebo M., Eisen J., Pinto A., Greenberg B., Dyck I., and Rasmussen S. The Brown Longitudinal Obsessive Compulsive Study: treatments received and patient impressions of improvement. Journal of Clinical Psychiatry 67 11 (2006) 1713-1720
18. Miller I.W., Bishop S., Norman W.H., and Maddever H. The Modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Research 14 2 (1985) 131-142
19. O'Sullivan G., Noshirvani H., Marks I., Monteiro W., and Lelliott P. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder. Journal of Clinical Psychiatry 52 4 (1991) 150-155
20. Pinto A., Mancebo M.C., Eisen J.L., Pagano M.E., and Rasmussen S.A. The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. Journal of Clinical Psychiatry 67 5 (2006) 703-711
21. Rasmussen S., Hackett E., DuBoff E., Greist J., Halaris A., Koran L.M., et al. A 2-year study of sertraline in the treatment of obsessive-compulsive disorder. International Clinical Psychopharmacology 12 6 (1997) 309-316
22. Simpson H.B., and Liebowitz M.R. Combining pharmacotherapy and cognitive-behavioral therapy in the treatment of OCD. In: Abramowitz J.S., and Houts A.C. (Eds). Concepts and controversies in Obsessive-Compulsive Disorder (2005), Springer, New York 359-376
23. SPSS Inc. (2006). SPSS Base 14.0 for Windows User's Guide. SPSS Inc., Chicago IL.